BUZZ-Verastem shares rise on positive ovarian cancer drug trial results
路透社2026/10/02 13:21October 2 - ** Verastem (VSTM.O) shares rose 1.8% in pre-market trading to $3.31
** The anti-cancer drug maker said that for patients with recurrent low-grade serous ovarian cancer lacking three key mutations, the treatment regimen of avutometinib combined with defactinib showed an objective response rate of 18%
** Reported that the median progression-free survival among patients was 13 months
** Added that this drug combination outperformed standard therapies
** Safety risks include eye problems, severe skin reactions, liver injury, and muscle damage; regular monitoring is required — VSTM
** Study results will be presented on Friday at the 2026 International Gynecologic Cancer Society (IGCS) annual meeting in Montreal
** As of the previous trading day's close, VSTM is up 2.33% year to date
(To assist non-native English speakers, Reuters has automated the translation of its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text, which is provided solely for the convenience of readers. Reuters accepts no liability for any damage or loss arising from the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Half a million miners stand between Bolivia and a critical minerals rush
US factory orders rose by 0.1% month-on-month in August; AI infrastructure supports manufacturing, but decline in aircraft orders offset part of the increase
The U.S. Census Bureau reported on Friday that factory orders in August increased by 0.1% month-on-month, in line with market expectations, and rose by 6.8% year-on-year. The July month-on-month increase was revised down from 0.9% to 0.8%. Orders for machinery and electrical equipment grew by 1.1% month-on-month, while orders for civilian aircraft and parts saw a significant decline of 4.3% month-on-month. Excluding aircraft, non-defense capital goods orders increased by 1.6% month-on-month.
ONDO falls below $0.5
Crypto prices
More
